Trial Profile
A Phase I Study Assessing the Effects of Rifampin on the Pharmacokinetics of Ataluren in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ataluren (Primary) ; Rifampicin
- Indications Cystic fibrosis; Duchenne muscular dystrophy; Mucopolysaccharidosis I
- Focus Pharmacokinetics
- Sponsors PTC Therapeutics
- 02 Mar 2017 Status changed to completed according to company (PTC Therapeutics) website.
- 10 Apr 2015 New trial record